Daniel S. Goldman bought CME Group Inc (NASDAQ: CME)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in CME Group Inc (CME) since 2023, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Daniel S. Goldman bought $1,001 - $15,000 of CME Group Inc (NASDAQ: CME) on January 31, 2023. Since that trade, CME is up +72.05% against the S&P 500 up +87.20%, an outperformance of -15.15%.
Data updated
Daniel S. Goldman's CME trades vs the price
CME is up +72.05% since Daniel S. Goldman bought on January 31, 2023, versus +87.20% for the S&P 500.
Performance since this trade
All Daniel S. Goldman CME trades
Daniel S. Goldman & CME trading FAQ
Is it legal for Daniel S. Goldman to trade CME Group Inc (CME) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CME Group Inc (CME), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman buy CME?
Daniel S. Goldman disclosed a purchase of $1,001 - $15,000 of CME Group Inc (CME) on January 31, 2023, according to public STOCK Act filings.
How has CME performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman bought CME on January 31, 2023, the stock is up +72.05%, versus +87.20% for the S&P 500 over the same period, an outperformance of -15.15%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CME trades?
Quantellect tracks every disclosed congressional trade in CME Group Inc (CME) on the CME Group Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's CME tradesAll congressional filings for CME Group IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.